The Center for Professional Innovation and Education (CfPIE) announces a new course: Pharmaceutical counterfeits and intellectual property rights infringement in China
This two-day course is intended to give attendees a detailed look into the growing problems of product counterfeiting, patent infringements and intellectual property rights violations in one of the world's fastest growing markets.
Directing this training session is CfPIE course director Dr Michael Li, a former forensic chemist for the US Customs Service, who has recently worked as a consultant with property rights investigators in Hong Kong and China.
Dr Li's experience spans both the investigative side of counterfeiting and intellectual property infringement, in addition to the chemical development of pharmaceutical products.
"Our mission at CfPIE is to provide training on issues which are critical to the pharmaceutical, medical device, biotech and skin/cosmetic industry.
"The problem surrounding the counterfeiting of products in China is one of those critical issues.
"We are thrilled to have Dr Li, one of the world's foremost authorities on the subject, directing this educational programme." stated Mark Mazzie, managing director of CfPIE.
Pirated and counterfeited pharmaceuticals are popular in China because of the profit potential and demand.
These look-alike pharmaceutical products cause tremendous damage to product image, trigger irreparable health damages to the consumer and often have a significant impact on the bottom line.
To protect both brands and the drug supply chain this course will familiarize attendees with current pharmaceutical counterfeiting activities, brand protection strategies and intellectual property (IP) rights infringement issues in China.
The course will initially be offered in CfPIE's Malvern, PA, location on 15 and 16 June 2006.
